US FDA Moves To Codify Size-Based Threshold For Drugs To Be Deemed Biologics

 
• By Bowman Cox
  
Insulin Monomer
Insulin, one of the drugs FDA will deem a biologic
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics